Prognostic Model of mRNA Alternative Splicing in GC and Prognostic Value of Splicing Factor QKI

Background: Alternative splicing (AS) dysregulation is increasingly implicated in gastric cancer (GC), but its genome-wide landscape remains incompletely characterized. Methods: We profiled RNA splicing patterns and percent-spliced-in (PSI) values in TCGA stomach adenocarcinoma (TCGA-STAD), integrating matched transcriptomic and clinical data. Differential alternative splicing events (DEAS) between tumor and adjacent normal tissues were identified and subsequently analyzed using survival analysis, Cox regression, and unsupervised clustering. Results: We detected 30,005 AS events, including 3563 DEAS. Among 16,827 quality-filtered AS events subjected to survival screening, 1018 were associated with overall survival, and 68 independent prognostic events were incorporated into exploratory prognostic models in the TCGA cohort. The integrated model showed apparent discriminatory performance within this cohort (apparent 3-year AUC = 0.937; bootstrap optimism-corrected 3-year AUC = 0.900), although external validation was not available. A splicing-associated network linking prognosis-related splicing factors with prognostic AS events further supported the identification of three exploratory AS-defined molecular clusters with different survival patterns. Unadjusted clinicopathological comparisons suggested nominal associations with selected variables, but these associations require cautious interpretation and independent validation. The splicing factor QKI was upregulated in GC, associated with poor prognosis, and further supported by external expression analysis as well as in vitro and in vivo functional assays. Conclusions: These findings provide an exploratory overview of AS dysregulation in GC, nominate candidate survival-associated AS events and splicing factors, and highlight QKI as a survival-associated splicing factor with functional relevance in gastric cancer models. Further external validation and mechanistic studies are required to determine the robustness and biological relevance of these exploratory findings.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2026-11-16
DOI
https://doi.org/10.3390/biomedicines14112649
Primary Topic
RNA Research and Splicing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prognostic Model of mRNA Alternative Splicing in GC and Prognostic Value of Splicing Factor QKI

Fei Su, Ruowen Xiao, Tao Zhang, Ruiyue Wu et al.
Biomedicines
RNA Research and Splicing
article

Prognostic Model of mRNA Alternative Splicing in GC and Prognostic Value of Splicing Factor QKI

Fei Su, Ruowen Xiao, Tao Zhang, Ruiyue Wu, Xiaoming Hou, Juanjuan Guo, Tianjiao Zhang, Xi Chen, Jingwei Cao, Peitong Jiang, Yongbin Lu
article en

Abstract

Background: Alternative splicing (AS) dysregulation is increasingly implicated in gastric cancer (GC), but its genome-wide landscape remains incompletely characterized. Methods: We profiled RNA splicing patterns and percent-spliced-in (PSI) values in TCGA stomach adenocarcinoma (TCGA-STAD), integrating matched transcriptomic and clinical data. Differential alternative splicing events (DEAS) between tumor and adjacent normal tissues were identified and subsequently analyzed using survival analysis, Cox regression, and unsupervised clustering. Results: We detected 30,005 AS events, including 3563 DEAS. Among 16,827 quality-filtered AS events subjected to survival screening, 1018 were associated with overall survival, and 68 independent prognostic events were incorporated into exploratory prognostic models in the TCGA cohort. The integrated model showed apparent discriminatory performance within this cohort (apparent 3-year AUC = 0.937; bootstrap optimism-corrected 3-year AUC = 0.900), although external validation was not available. A splicing-associated network linking prognosis-related splicing factors with prognostic AS events further supported the identification of three exploratory AS-defined molecular clusters with different survival patterns. Unadjusted clinicopathological comparisons suggested nominal associations with selected variables, but these associations require cautious interpretation and independent validation. The splicing factor QKI was upregulated in GC, associated with poor prognosis, and further supported by external expression analysis as well as in vitro and in vivo functional assays. Conclusions: These findings provide an exploratory overview of AS dysregulation in GC, nominate candidate survival-associated AS events and splicing factors, and highlight QKI as a survival-associated splicing factor with functional relevance in gastric cancer models. Further external validation and mechanistic studies are required to determine the robustness and biological relevance of these exploratory findings.

BiomedicinesVol. 14(11)
First Hospital of Lanzhou University (CN), Lanzhou University (CN)
Good health and well-being
RNA Research and Splicing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon